ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière destiné aux personnes atteintes de lésion chronique de la moelle épinière
19 déc. 2024 11h58 HE
|
ONWARD Medical NV
CE COMMUNIQUÉ DE PRESSE CONTIENT DES INFORMATIONS PRIVÉES AU SENS DE L'ARTICLE (7)(1) DU RÈGLEMENT EUROPÉEN SUR LES ABUS DE MARCHÉ (596/2014)Le système ARC-EX® est la première et unique technologie...
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury
19 déc. 2024 11h58 HE
|
ONWARD Medical NV
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System
ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability
12 déc. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability
ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights
26 nov. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights
ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke
19 nov. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD Medical Awarded Grant to Study Potential for ARC
BCI Therapy to Restore Movement after Stroke
ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights
12 nov. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights
ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024
31 oct. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD ARC-EX® System Named One of TIME's Best
Inventions of 2024
ONWARD® Medical Publishes Closing of Bookbuild Offering
28 oct. 2024 12h45 HE
|
ONWARD Medical NV
ONWARD® Medical Publishes Closing of Bookbuild Offering
ONWARD® Medical Publishes Prospectus for Listing of New Shares
24 oct. 2024 11h45 HE
|
ONWARD Medical NV
ONWARD® Medical Publishes Prospectus for Listing of New
Shares
ONWARD® Medical lève avec succès 50 millions d’euros dans le cadre d’une levée de fonds majorée avec le soutien d’Ottobock SE & Co. KGaA
24 oct. 2024 01h30 HE
|
ONWARD Medical NV
Ottobock, un leader mondial dans le domaine des prothèses, des orthèses et des exosquelettes, acquiert environ 10% du capital d’ONWARD Medical N.V. concrétisant un partenariat stratégique La...